No Can do: 'Undervalued' Theratechnologies pulls US offering despite Egrifta approval
This article was originally published in Scrip
Executive Summary
Theratechnologies has decided to withdraw its public offering in Canada and the US as the Canadian company believes it has "a much higher intrinsic value than what the market is currently reflecting". It filed the preliminary prospectus for the offering, which would have marked its IPO in the US, just two weeks ago.